Stem Cells USA is where experts like Organogenesis' Jasmin Kee meet to network, learn from each other, and discuss the latest stem cells strategies and technology.

Organogenesis on Large Scale Manufacturing with Process Engineered Robotic Design

Jasmin Kee, Manager of Process Engineering at Organogenesis, presented at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download her presentation slides from the event, where she addresses large scale manufacturing with process engineered robotic design. You can view the recording of her presentation alongside these slides, so that you can both hear her presentation and …

The Stem Cell Industry walking on a tightrope

Recently there has been a huge controversy centered on the integrity and validity of research by the German stem cell research group of Bodo-Eckehard Strauer (Read Here). Strauer became well known in the industry because of his publication on an autologous bone marrow-derived stem cell therapy in heart disease, however he was criticized for basing his results on a single …

Effectively deploying QbD in cell culture and upstream processes optimization

"Scientists are the parents of cell culture", this sounds like a rather absurd statement, doesn't it? I actually think that this is an excellent metaphor. When you look at a successful mammalian cell culture process, it required meticulous attention and control due to the different individual physiology and growth requirements of these cells. Therefore, this is a perfect comparison to …

Increasing struggles in cell therapies manufacturing as production ramps up

Even though there has been an increasing number of cell therapies advancing to late-stage clinical development, several aspects of cell therapy development continue to present considerable challenges for large scale commercialization. It is clear that production of biologics in general carries higher risks than of small molecules pharmaceuticals and this becomes even more evident as production of cell therapies ramps …